Sign in
BLAC Stock Price, Chart, Stats & News
Bellevue Life Sciences Acquisition Corp.
Save
6.98M
Market cap
–
Current P/E
–
Forward P/E
BLAC chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 18.35% |
Operating margin | -558.30% |
Pretax margin | -913.36% |
Net margin | -864.93% |
Effective tax rate | 7.87% |
ROA | -12.32% |
ROE | -21.88% |
D/E | 0.00x |
Interest coverage ratio | -260.12x |
BLAC valuation
P/E | – |
P/S | 2.77x |
P/B | 0.10x |
P/CF | -3.59x |
P/FCF | -1.86x |
P/OCF | -3.59x |
PEG | 0.04x |
EV multiple | -0.89x |
About
Bellevue Life Sciences Acquisition Corp. currently does not engage in substantial operational activities. Its core mission is to orchestrate a business combination, which could manifest as a merger, share exchange, asset acquisition, stock purchase, recapitalization, or reorganization, with one or more enterprises or organizations within the healthcare domain. This firm, established in 2020, maintains its principal office in Bellevue, Washington, and operates as a subordinate entity of Bellevue Global Life Sciences Investors LLC.
Similar securities
Based on sector and market capitalization
Report issue